Animal-to-human transplant of insulin-producing cells without use of drugs is ultimate goal
In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.
Northwestern scientists developed a new method that prevented rejection of the islets, a huge problem in transplants between species, called xenotransplantation. “This is the first time that an interspecies transplant of islet cells has been achieved for an indefinite period of time without the use of immunosuppressive drugs,” said study co-senior author Stephen Miller. “It’s a big step forward.” “Our ultimate goal is to be able to transplant pig islets into humans, but we have to take baby steps,” said Xunrong Luo, M.D., also co-senior author of the study that will be published online July 12 in the journal Diabetes. “Pig islets produce insulin that controls blood sugar in humans.”
Luo is an associate professor of nephrology at Northwestern University Feinberg School of Medicine and medical director of the Human Islet Cell Transplantation Program at Northwestern Memorial Hospital. Miller is the Judy Gugenheim Research Professor of Microbiology-Immunology at Feinberg. For people with hard-to-control type 1 diabetes, a transplant of insulin-producing islets from a deceased donor is one important way to control their chronic disease, in which their bodies do not produce insulin. However, there is a severe shortage of islet cells from deceased donors. Many patients on waiting lists don’t receive the transplant or suffer damage to their heart, nerves, eyes and kidneys while they wait.
Using islets from another species would provide wider access to transplants for humans and solve the problem. But concerns about controlling rejection of transplants from a different species have made that approach seem insurmountable until now. In the new study, scientists persuaded the immune systems of mice to recognize rat islets as their own and not reject them. Notably, the method did not require the long-term use of drugs to suppress the immune system, which have serious side effects. The islets lived and produced insulin in the mice for at least 300 days, which is as long as scientists followed the mice.
While the barrier from rats to mice is probably lower than from pigs to humans, the study showed interspecies islet transplants are possible and without immunosuppressive drugs, Luo said. In the study, the rat splenocytes, a type of white blood cell located in the spleen, were removed and treated with a chemical that caused their deaths. Next, the dead splenocytes were injected into the mice. The cells entered the spleen and liver and were mopped up by scavenger cells.
The scavengers processed the splenocytes and presented fragments of them on their cell surface, triggering a reaction that told the T cells to accept the subsequently transplanted rat islets and not attack them.
But rejection was still a threat. A unique challenge of an interspecies transplant is controlling the B cells, immune cells that are major producers of antibodies. Initially, when scientists transplanted the rat islets into the mice, the mouse immune system started producing antibodies against the rat cells causing rejection.
To solve the problem, Luo realized she needed to kill off the B-cells at the same time she injected the donor islets into the mice. Thus, she gave the mice B-cell depleting antibodies — already used in a clinical setting in human transplants. When the B-cells naturally returned after the transplant, they no longer attacked the rat islets. “With this method, 100 percent of the islets survived indefinitely,” Luo said. “Now we’re trying to figure out why the B-cells are different when they come back.”
The Latest Bing News on:
Interspecies Transplant
- Cross-species liver cell growth could represent a solution to transplant shortageon May 8, 2024 at 10:24 pm
Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.
- Could rat brain cells in mice help grow human organs in animals? A new study offers clueson May 7, 2024 at 9:42 am
Scientists based in China and the United States have grown the first functional rat cells within the brains of mice, a development that they say could help grow organs from human cells in animals.
- A Case of Polyomavirus-associated Nephropathy Presenting Late After Transplantationon May 4, 2024 at 5:00 pm
Background: A 36-year-old white female, who had received a deceased-donor kidney transplant for end-stage renal disease secondary to reflux nephropathy 8 years previously, was referred to a ...
- Rat Neurons Repair Mouse Brains That Lack a Sense of Smellon April 30, 2024 at 12:27 pm
With an injection of rat cells, mouse brains that were genetically engineered to be unable to smell could detect odors and even track down an Oreo cookie stash ...
- Hybrid Brains: Mice with Rat Neurons Sense Smellson April 25, 2024 at 11:02 am
Researchers made a groundbreaking advancement by developing mice with hybrid brains containing rat neurons, allowing them to perceive odors like rats.
- Grandma too sick for traditional transplant first woman to be given pig kidneyon April 24, 2024 at 4:18 pm
She becomes only the second person to undergo a pig kidney transplant, hot on the heels of a similar operation last month at Massachusetts General Hospital, as scientists push the boundaries to ...
- Cell Transplantation for Huntington's Disease: Practical and Clinical Considerationson April 13, 2024 at 5:00 pm
Pyrexial illness with CSF lymphocytosis following discontinuation of immunosuppression at 12 months [70] Cognition assessed at 2 months pretransplant and 4–6 months post-transplant, some ...
- How kidney transplant reforms can save lives and reduce the deficiton April 13, 2024 at 7:26 am
For months, Congress has debated budget bill after budget bill, narrowly missing government shutdown deadlines seemingly every month. With a divided Congress and narrow majorities in both chambers ...
- Houston transplant surgeon accused of altering records to deny patients organs; program suspendedon April 12, 2024 at 11:48 am
A decorated transplant surgeon in Houston, Texas is being accused of depriving his patients of new livers by exploiting a government database and changing their records. Dr. J. Steve Bynon Jr. has ...
- First pig kidney in a human: Is this the future of transplants?on April 11, 2024 at 5:00 pm
The first man to receive a genetically modified kidney transplant from a pig was discharged from hospital on Wednesday last week. Richard “Rick” Slayman, 62, who had been suffering from end ...
The Latest Google Headlines on:
Interspecies Transplant
[google_news title=”” keyword=”Interspecies Transplant” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diabetes Therapy
- Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabeteson May 9, 2024 at 4:20 am
Innovent has scored another phase 3 win for mazdutide as the drug showed its superiority to Eli Lilly's diabetes and heart drug Trulicity when it came to glycemic control in patients with Type 2 ...
- Type 2 Diabeteson May 8, 2024 at 3:38 pm
The main goal of diabetes treatment is to keep your blood sugar levels in target range. To help monitor them, your doctor will order blood work on a regular basis, including an A1C test.
- Cell therapy fails to slow early type 1 diabetes, but safety is establishedon May 8, 2024 at 11:00 am
Despite the negative finding, researchers said there is still promise in the strategy of amplifying and infusing the immune cells of newly diagnosed type 1 diabetes patients.
- Don't Overlook Cardiovascular Risk in Type 1 Diabeteson May 8, 2024 at 7:56 am
Cardiovascular disease management is an often overlooked but critical aspect of care for people with type 1 diabetes, authors of a new review paper said. Cardiovascular disease is the most common ...
- Medications & Treatmenton May 8, 2024 at 3:18 am
Here's our process. Which type 2 diabetes treatment is right for you? If lifestyle changes alone don’t allow you to meet your blood sugar and A1C goals, your doctor may prescribe medication.
- Ancient grains linked to improved type 2 diabetes outcomeson May 4, 2024 at 7:52 am
A new study suggests ancient grain consumption is associated with improved health outcomes for people with type 2 diabetes. Ancient grains like oats are rich in dietary fiber and phytochemicals that ...
- How True Captive Insurance’s proactive health care approach transformed a 10-year-old’s treatment for diabeteson April 30, 2024 at 10:00 pm
A proactive approach can be transformative in health care, especially when it comes to managing chronic conditions.
- Early gestational diabetes treatment shown to reduce birth complications, health costs for those at higher riskon April 30, 2024 at 10:23 am
New research led by Western Sydney University has shown that treatment of gestational diabetes from early pregnancy can not only reduce birth complications among babies and mothers, but can also ...
- Bioengineer explores new approach to diabetes treatmenton April 29, 2024 at 12:31 pm
The chair of the Bioengineering Department at The University of Texas at Arlington is working on an invention that will allow for better treatment of Type 1 diabetes patients.
- American College Of Physicians Officially Recommends GLP-1s Like Ozempic For Diabetes Treatment—Despite Shortage Concernson April 19, 2024 at 10:10 am
The American College of Physicians issued new guidelines for Type 2 diabetes treatment, which for the first time recommends the use of GLP-1s and another class of diabetes drugs called SGLT-2s ...
The Latest Google Headlines on:
Diabetes Therapy
[google_news title=”” keyword=”Diabetes Therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]